CMV-specific immune reconstitution following allogeneic stem cell transplantation.

about

Infections following allogeneic stem cell transplantation: New concepts, improved insights, and renewed hope for better outcomes.Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line.

P2860

Q40478054-B705E0D0-27EF-4EA9-AAF5-F4606C249A9D Q47548299-2A46AE1E-870B-4471-ADA3-1313EE784AF9

P2860

CMV-specific immune reconstitution following allogeneic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q38942459

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

CMV-specific immune reconstitution following allogeneic stem cell transplantation.

@en

type

Item

label

CMV-specific immune reconstitution following allogeneic stem cell transplantation.

@en

prefLabel

CMV-specific immune reconstitution following allogeneic stem cell transplantation.

@en

P1476

CMV-specific immune reconstitution following allogeneic stem cell transplantation.

@en

P2093

Barbara Withers

http://www.w3.org/2001/XMLSchema#string

Leighton Clancy

http://www.w3.org/2001/XMLSchema#string

P2860

Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.

Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.

Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial

Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy.

The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches.

Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.

A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.

Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice

P304

967-980

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21505594.2016.1221022

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emily Blyth

David J Gottlieb

P577

2016-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27580355

http://www.w3.org/2001/XMLSchema#string

P932

5160403

http://www.w3.org/2001/XMLSchema#string

CMV-specific immune reconstitution following allogeneic stem cell transplantation.

about

P2860

P2860

CMV-specific immune reconstitution following allogeneic stem cell transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932